Article Details

EC approves Venclyxto-based combinations for newly diagnosed AML

Retrieved on: 2021-05-26 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

EC approves Venclyxto-based combinations for newly diagnosed AML. View article details on hiswai:

Excerpt

The European Commission (EC) has approved Roche's Venclyxto in combination with azacitidine and decitabine for the treatment of newly diagnosed ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up